Explained:How China proposes to treat Alzheimer’s with new drug

2 min read

News:Recently,China has approved the world’s first multi-targeting and carbohydrate-based drug GV-971 for Alzheimer’s disease.

Facts:

About Drug GV-971:

  • The drug has been extracted from brown algae and can treat mild to moderate forms of Alzheimer’s disease and improve cognition.
  • It is the world’s first multi targeting drug.The drug can be taken orally by the patients.
  • Multi-target drugs hit several targets in the body which is often necessary to do in order to yield a therapeutic effect in complex diseases like Parkinson’s or Alzheimer’s. 
  • This is different from most drugs which target only a single biological substance, like a protein or enzyme.

Additional information:

About Alzheimer’s disease:

  • Alzheimer’s disease is a progressive brain disorder that typically affects people older than 65. 
  • The disease destroys brain cells and nerves and disrupts the message carrying neurotransmitters.
  • There is no treatment that cures Alzheimer’s disease or alters the disease process in the brain.Most drugs being developed try to slow down or stop the progression of the disease.